Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...

The city of Beaumont is seeking to determine the feasibility of combining the Beaumont Children’s Museum with the Downtown ...

A new study reports that a routine, low-cost nutritional assessment tool may offer a powerful way to predict survival in patients with progressive pulmonary fibrosis (PPF), a life-shortening condition ...

This fundamental study presents experimental evidence on how geomagnetic and visual cues are integrated in a nocturnally migrating insect. The evidence supporting the conclusions is compelling. The ...

Background Drug–drug interaction (DDI) alerts target the co-prescription of two potentially interacting medications and are a ...

Shares in gene-editing specialist Intellia Therapeutics came under renewed pressure today after a patient in one of its clinical trials who was hospitalised for liver toxicity died. The company's ...

Alnylam Pharmaceuticals ((ALNY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

− Generated Q3 2025 Total Net Product Revenues of $851 Million (103% Growth Compared with Q3 2024), Driven Primarily by Total TTR Revenues of $724 Million (135% Growth Compared with Q3 2024) – − ...

Intellia earlier this year reported a similar grade 4 liver enzyme elevation associated with the gene therapy nexiguran ziclumeran, though analysts at BMO Capital Markets at the time brushed it off as ...

Humans interact with each other with the help of different complex languages, which include words, grammar, and symbols, to share ideas, emotions, and information. On the other hand, animals just rely ...

As schools reopen this week, students are returning to classrooms where AI-powered tools are becoming more commonplace. According to a study from the Walton Family Foundation and Gallup, six in 10 ...